Acute Coronary Syndromes Flashcards

1
Q

ACS: Signs/Sx

A

-Chest pain (pressure/squeezing)
>10 min, dyspnea, diaphoresis, radiate to arms/back/neck/jaw

-Pts with SL NTG RX should use 1 dose every 5 minutes for up to 3 doses to relieve chest pain
-If chest pain is not improved or is worse 5 minutes after the
first dose, they should call 911 immediately

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

UA vs NSTEMI vs STEMI

A

UA: negative cardiac enzymes, no ECG changes or ST dep/T waves, partial blockade

NSTEMI: positive cardiac enzymes, no ECG changes or ST dep/T waves, partial blockade

STEMI: positive cardiac enzymes, ST elevation, complete blockade

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

PCI

A

-Inflating balloon inside coronary artery to widen it and improve blood flow (revascularization procedure)

NST-ACS: PCI or med mgmt

STEMI: PCI or fibrolysis
-PCI preferred, if it can be done within 90 min (door-to-balloon) or within 120 min (from first medical contact)
-If PCI not possible within 120 min, fibrinolytic tx within 30 min (door-to-needle)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Drug Tx

A

Morphine
Oxygen
Nitrates
Aspirin

G PIIb/IIIa antagonists
Anticoagulatns
P2Y12 inhibitors

Beta-blockers
ACE inhibitors

-NSTE-ACS: MONA-GAP-BA +/- PCI
-STEMI: MONA-GAP-BA + PCI or fibrinolytic (PCI preferred)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Morphine

A

-Pain relief
-Not for routine use (shown to diminish AP effects), reserve for pts with unaccepbble chest discomfort
-Dose: 2-5 mg IV q 5-30 min PRN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Oxygen

A

Oxygen Sat <90% or respiratory distress

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Nitrates

A

SL NTG 0.4 mg q5 min x3 doses (if not already given)

If sx persist: IV NTG
-Do not use IV NTG if SBP < 90, HR < 50, or RIGHT ventricular infarction
-CI WITH PDE5 inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Aspirin

A

-No enteric coated: CHEWABLE (fast)
-Dose: 162-325 mg ASAP
-Maintenance: 75-100 mg indefinitely

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Give within 24 hours of ACS

A

-BB: B1 selective agent (AMEBBA)
*If has HFrEF: biso, meto, carve

-ACEi: in all pts LVEF < 40%, DIA, CKD, HTN
*ARB if ACEi is intolerable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Meds To Avoid In Acute Setting

A

-NSAIDs
-IR Nifedipine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Clopidogrel (Plavix)

A

LD 300-600 mg (600 mg for PCI)
MD 75 mg daily

Prodrug, CYP2C19 PM

CI: serious active bleeding
-Stop 5 days prior to elective surgery

DDI: don’t use with omeprazole/eso

AE: thrombotic thrombocytopenia purpura (TTP)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Prasugrel (Effient)

A

LD 60 mg (max 1 hour after PCI)
MD 10 mg daily with asa

Protect from light, OG CONTAINER

BBW: bleeding

Do not initiate if CABG
-Stop 7 days prior to elective surgery

CI: serious active bleeding, TIA/stroke hx

AE: TTP, bleeding risk (higher than plavix)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Ticagrelor (Brillinta)

A

LD 180 mg
MD 90 mg BID x1 year, 60 mg BID

BBW: bleeding

-Max MD 100 mg ASA (ASA can decrease effectiveness of tica)

Do not initiate if CABG
-Stop 5 days prior to any surgery

CI: serious bleeding

AE: TTP, dyspnea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Cangrelor (Kengreal)

A

Injection

Only indicated as an adjunct to PCI in pts who are P2Y12 inhibitor naive and are not receiving a GPllb/llla inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

P2Y12 Inhibitor DDIs

A

Clopidogrel, Ticagrelor, Prasugrel, Cangrelor

Other meds that increase bleeding risk
-Warfarin, NSAIDs, SSRI, SNRI

Clopidogrel: CI with omeprazole/eso

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Glycoprotein IIb/IIIa RA

A

Eptifibatide, Tirofiban, Abciximab

AE: bleeding, thrombocytopenia

CI: PLT <100k, active bleeding, uncontrolled HTN, recent major surgery/trauma, stroke within 30d (eptif)
(SESH PB)

17
Q

Vorapaxar (Zontivity)

A

Indicated in patients with a history of MI or peripheral arterial disease (PAD) to reduce thrombotic events

18
Q

Fibrinolytics: Overview

A

Alteplase, Tenecteplase

Cause fibrinolysis (break up clots)

Used only for STEMI
-Given within 30 min (door-to-needle)

19
Q

Alteplase (Activase): Dosing

A

> 67 kg: 100 mg over 1.5 hours:
-15 mg bolus
-50 mg over 30 min
-35 mg over 1 hour

67 or < kg:
-15 mg bolus
-0.75 mg/kg (max 50 mg) over 30 min
-0.5 mg/kg (max 35 mg) over 1 hour
-Max total 100 mg

20
Q

Tenecteplase (TNKase): Dosing

A

Single IV bolus dose:

< 60 kg: 30 mg
60-69 kg: 35 mg
70-79 kg: 40 mg
80-89 kg: 45 mg
90 kg: 50mg

21
Q

Alteplase/Tenecteplase: CI/AE

A

CI: HIS BI
-active internal bleeding
-hx of recent stroke
-prior ICH
-recent intracranial/intraspinal surgery/trauma
-severe uncontrolled HTN (no response to tx)

AE: bleeding (ICH)

Monitor: Hgb, Hct, bleeding

22
Q

Secondary Prevention of ACS

A
  1. Aspirin (indefinitely)
  2. DAPT:
    -MM: Tica/Clop + ASA for at least 12 months
    -PCI: Tica/Clop/Pras + ASA for at least 12 months
  3. NTG
  4. BB x3 years (indefinitely if HF/HTN)
  5. ACEi (indefinitely if LVEF < 40, HTN, DIA, CKD, MI)
  6. Aldosterones (SE, unless CI with Scr/K)
  7. Statins
23
Q

Other Considerations

A

-Pain: naproxen has lowest CV risk
-ACS + AF: triple antithrombitic therapy can be used (shortest time possible, clop preferred for triple, PPIs for GI bleed hx)
-Lifestyle modifications